Percutaneous Left Atrial blind-ended structure: a review of its echocardiographic evaluation and Appendage Closure vs Warfarin for Atrial Fibrillation: A Randomized its clinical role[ J]. Chest, 2005, 128:1853- 1862. Clinical Trial[ J]. JAMA, 2014, 312:1988- 1998. [20] Manning WJ, Weintraub...
WASHINGTON, DC — New, longer-term data on the Watchman left atrial appendage occluder (Boston Scientific) studied in the PREVAIL trial points to an increased risk of ischemic stroke in atrial-fibrillation patients treated with this novel device, a finding that appears to be countered, in part,...
Safety of percutaneous left atrial appendage closure: results from the Watchman left atrial appendage system for embolic protection in patients with AF (PROTECT AF) clinical trial and the continued access registry Circulation, 123 (2011), pp. 417-424 Google Scholar 13 S.E. Kasner Clinical interpre...
Assessment of Device-Related Thrombus and Associated Clinical Outcomes With the WATCHMAN Left Atrial Appendage Closure Device for Embolic Protection in Patients With Atrial Fibrillation (from the PROTECT-AF Trial)[J] . Michael L. Main,Dali Fan,Vivek Y. Reddy,David R. Holmes,Nicole T. Gordon,...